SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based therapies for ...

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in ...

Among a group of veterans discharged from the hospital after acute kidney injury or heart attacks, death occurred most often in patients who experienced both conditions and least often in patients ...

Washington, DC (February 5, 2015) -- A simple test can help predict which patients with acute kidney injury will likely develop serious kidney problems and die in the hospital, according to a study ...

One type of open heart surgery is safer than the other—in terms of both health and survival—for chronic kidney disease patients. Heart disease is the leading cause of death in individuals with chronic ...

HAYWARD, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative ...

Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based therapies for the prevention and treatment ...

Please provide your email address to receive an email when new articles are posted on . Acute kidney injury may be more deadly than a heart attack, according to a study appearing in an upcoming issue ...